New York Life Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.03M | Buy |
89,911
+229
| +0.3% | +$17.9K | 0.07% | 254 |
|
|
2025
Q1 | $6.5M | Sell |
89,682
-1,151
| -1% | -$83.4K | 0.07% | 264 |
|
|
2024
Q4 | $6.72M | Sell |
90,833
-332
| -0.4% | -$24.6K | 0.07% | 257 |
|
|
2024
Q3 | $6.02M | Sell |
91,165
-2,677
| -3% | -$177K | 0.06% | 299 |
|
|
2024
Q2 | $8.67M | Buy |
93,842
+256
| +0.3% | +$23.6K | 0.09% | 215 |
|
|
2024
Q1 | $8.94M | Sell |
93,586
-3,145
| -3% | -$301K | 0.09% | 209 |
|
|
2023
Q4 | $7.38M | Buy |
96,731
+484
| +0.5% | +$36.9K | 0.08% | 229 |
|
|
2023
Q3 | $6.67M | Buy |
96,247
+467
| +0.5% | +$32.4K | 0.07% | 253 |
|
|
2023
Q2 | $9.03M | Sell |
95,780
-1,846
| -2% | -$174K | 0.09% | 203 |
|
|
2023
Q1 | $8.08M | Buy |
97,626
+113
| +0.1% | +$9.35K | 0.09% | 228 |
|
|
2022
Q4 | $7.28M | Sell |
97,513
-494
| -0.5% | -$36.9K | 0.08% | 244 |
|
|
2022
Q3 | $8.1M | Sell |
98,007
-444
| -0.5% | -$36.7K | 0.1% | 217 |
|
|
2022
Q2 | $9.36M | Buy |
+98,451
| New | +$9.36M | 0.11% | 197 |
|